Non news is good news for Lilly

  • Comments
  • Print

Eli Lilly and Co.â??s announcement this morning that President and Chief Operating Officer John Lechleiter would succeed CEO
Sidney Taurel in April was a picture of smooth succession planning.

Lechleiterâ??s ascension had been expected for so long that the news was hardly news.

The markets certainly werenâ??t thrown for a loop. Lilly shares have traded between $53.17 and $54 all day â?? not so different
from the past couple of weeks.

Itâ??s the second smooth succession in a row for Lilly. Randy Tobias, in fact, prides himself on grooming Taurel as his replacement.

Youâ??ve probably seen a few transitions at organizations where youâ??ve worked. Howâ??s the best way for top executives to hand
over control of a company?

Read the story.


Please enable JavaScript to view this content.

Editor's note: IBJ is now using a new comment system. Your Disqus account will no longer work on the IBJ site. Instead, you can leave a comment on stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Past comments are not currently showing up on stories, but they will be added in the coming weeks. Please note our updated comment policy that will govern how comments are moderated.